Genzyme Reports More Good News For Mozobil
This article was originally published in The Pink Sheet Daily
Executive Summary
Second Phase III trial shows twice the stem cell mobilization power called for in multiple myeloma protocol, adding to high efficacy shown in lymphoma study reported in July.